Uveitic macular edema response to intravitreal dexamethasone implant is independent of optical coherence tomography findings.
Aina Moll-UdinaMarc Figueras-RocaJoan OliveresAnna Sala-PuigdollersCristina EsquinasCarmen Alba-LineroVíctor Llorenç-BellesAlfredo Manuel Adán CiveraPublished in: International ophthalmology (2020)
DEX implant is an effective treatment for UME independently of basal characteristics, producing both a gain of visual acuity and improvement of macular anatomy by OCT measures at 3 months.